Elexacaftor/tezacaftor/ivacaftor May be Effective in Treating Sinonasal Disease in Patients with Cystic Fibrosis

The combination of lexacaftor/tezacaftor/ivacaftor has been shown to have positive effects on multiple organ systems.

Source: ENTtoday - TRIO Best Practices - October 3, 2023 Category: ENT & OMF Authors: Tyler B. Merrill, MD, Jonathan Tyes, BS, and Troy D. Woodard, MD Tags: Practice Focus Rhinology TRIO Best Practices Cycstic Fibrosis Sinonasal Disease Source Type: research